[
    [
        {
            "time": "",
            "original_text": "深圳医药行业上市公司成立专业委员会",
            "features": {
                "keywords": [
                    "深圳",
                    "医药",
                    "专业委员会"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "深圳医药行业上市公司成立专业委员会",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "华大基因(300676.SZ)4名董监将其间接持有部分公司股票转至个人名下并增持",
            "features": {
                "keywords": [
                    "华大基因",
                    "董监",
                    "增持"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华大基因(300676.SZ)4名董监将其间接持有部分公司股票转至个人名下并增持",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "粤港澳大湾区最具创新力榜单：医药与生命科学TOP30",
            "features": {
                "keywords": [
                    "粤港澳大湾区",
                    "创新力",
                    "医药",
                    "生命科学"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生命科学"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "粤港澳大湾区最具创新力榜单：医药与生命科学TOP30",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "华大基因：子公司新冠病毒核酸检测产品获巴西ANVISA认证",
            "features": {
                "keywords": [
                    "华大基因",
                    "新冠病毒",
                    "核酸检测",
                    "巴西",
                    "ANVISA认证"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华大基因：子公司新冠病毒核酸检测产品获巴西ANVISA认证",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "华大基因：华大投资其合伙企业认缴出资金额变更为2941.25万元",
            "features": {
                "keywords": [
                    "华大基因",
                    "华大投资",
                    "出资金额变更"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "华大基因：华大投资其合伙企业认缴出资金额变更为2941.25万元",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "华大基因公告，全资子公司华大生物科技（武汉）有限公司的新型冠状病毒核酸检测试剂盒获得了巴西国家卫生监督局的认证",
            "features": {
                "keywords": [
                    "华大基因",
                    "核酸检测试剂盒",
                    "巴西",
                    "认证"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华大基因公告，全资子公司华大生物科技（武汉）有限公司的新型冠状病毒核酸检测试剂盒获得了巴西国家卫生监督局的认证",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "华大基因(300676.SZ)：新型冠状病毒2019-nCoV核酸检测试剂盒(荧光PCR法)获得巴西ANVISA认证",
            "features": {
                "keywords": [
                    "华大基因",
                    "核酸检测试剂盒",
                    "荧光PCR法",
                    "巴西",
                    "ANVISA认证"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华大基因(300676.SZ)：新型冠状病毒2019-nCoV核酸检测试剂盒(荧光PCR法)获得巴西ANVISA认证",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "深圳上市公司协会会员“圆桌会议”暨“走进华大基因”活动顺利举行",
            "features": {
                "keywords": [
                    "深圳上市公司协会",
                    "圆桌会议",
                    "华大基因"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "深圳上市公司协会会员“圆桌会议”暨“走进华大基因”活动顺利举行",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "医疗健康产业2021年投资策略：医疗投资迎来长跑期 关注医保控费下的新机遇",
            "features": {
                "keywords": [
                    "医疗健康",
                    "投资策略",
                    "医保控费",
                    "新机遇"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "医疗健康"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医疗健康产业2021年投资策略：医疗投资迎来长跑期 关注医保控费下的新机遇",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]